Cambridge Cognition Holdings PLC New digital health contract worth over GBP700,000
December 21 2020 - 2:00AM
RNS Non-Regulatory
TIDMCOG
Cambridge Cognition Holdings PLC
21 December 2020
Cambridge Cognition Holdings Plc
(" Cambridge Cognition" or the "Company")
Cambridge Cognition wins new digital health contract worth over
GBP700,000
Cambridge Cognition Holdings plc (AIM: COG), which develops and
markets digital solutions to assess brain health, is pleased to
announce that it has won a new contract with a major pharmaceutical
client to provide digital assessments of mood and cognition for a
depression trial. The contract is worth over GBP700,000 with most
of the revenue expected to be recognised in 2021.
Impairments in cognition can persist after recovery from a
period of depression and this can contribute to difficulties in
reaching a full recovery. So, in efforts to thoroughly assess
treatment efficacy, Cambridge Cognition has been contracted to
deploy remote assessments of mood and cognition over a 12-month
period. The assessments will be delivered on patients' mobile
phones with their performance and wellbeing monitored by the
pharmaceutical client.
The inclusion of remote and brief assessments during both the
core and extension periods of the trial will provide the client
with a better understanding of the relationships between mood,
cognition and recovery. Cambridge Cognition is in a unique position
to support the delivery of this trial with expertise in both
gold-standard cognitive assessment and innovative digital health
solutions for frequent, remote testing.
Matthew Stork, Chief Executive Officer of Cambridge Cognition,
said:
" We are excited to be working with another pharmaceutical
company that recognises the importance of frequent objective
cognitive assessments in the development of treatments for central
nervous system disorders. This new contract further validates the
Company's strategy as again we will be configuring existing digital
health solutions rather than undertaking bespoke software
development. It also further highlights the opportunity available
to Cambridge Cognition to provide remote, patient-centred solutions
in the CNS market."
For further information, contact:
Cambridge Cognition Holdings PLC Tel: 012 2381 0700
Matthew Stork, Chief Executive Officer press@camcog.com
Nick Walters, Chief Financial Officer
finnCap Ltd (NOMAD and Joint Broker) Tel: 020 7220 0500
Geoff Nash / Simon Hicks (Corporate Finance)
Alice Lane / Sunila de Silva (Corporate Broking)
Dowgate Capital Limited (Joint Broker) Tel: 020 3903 7715
David Poutney / James Serjeant
IFC Advisory Ltd (Financial PR and IR) Tel: 020 3934 6630
Tim Metcalfe / Graham Herring / Zach Cohen
Notes to Editors
About Cambridge Cognition
Cambridge Cognition is a neuroscience technology company
developing digital health products to better understand, detect and
treat conditions affecting brain health. The company's software
products assess cognitive health in patients worldwide to improve
clinical trial outcomes, identify and stratify patients early and
improve global efficiency in pharmaceutical and healthcare
industries.
For further information visit www.cambridgecognition.com
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRABLBDDRUDDGGG
(END) Dow Jones Newswires
December 21, 2020 02:00 ET (07:00 GMT)
Cambridge Cognition (LSE:COG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cambridge Cognition (LSE:COG)
Historical Stock Chart
From Apr 2023 to Apr 2024